Refine by
Regulatory Data Articles & Analysis
5 articles found
Medical advancement relies on clinical trials, which are essential for the development of safe and effective innovative treatments. However, the success and general applicability of these treatments heavily depend on the diversity of the participants involved¹?³. This blog explores the importance of achieving data diversity in clinical trials to enhance clinical trial results and ...
With the ability to rapidly produce large volumes of sequencing data, next-generation sequencing (NGS) enables researchers to obtain whole genome or targeted regions of samples. ...
This is the area where many of the bio-pharma, consumer healthcare, medical device manufacturers, R&D department, CROs and regulatory agencies face challenges. All companies need clear guidelines on when, how, and at which stage they have need regulatory submissions. ...
ByDDi LLC
Building on these concepts, the approach takes into account indirect exposure of potential consumers such as fish‐eating mammals and humans, as well as primary producers (e.g., algae) and primary and secondary consumers (e.g., invertebrates and fish). Although chronic toxicity data are preferred for ERC derivation, acute data, with appropriate considerations of ...
These notebooks, which focus on key indicators that holistically present air, water, and land pollutant release data, have been thoroughly reviewed by experts from both inside and outside the EPA. ...